Submissions from 2020
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants, Jorge Perez
Full Text Restricted – Available from BHSF IP or login only
Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial, Jorge Perez
Full Text Restricted – Available from BHSF IP or login only
High-Dose Erythropoietin in Extremely Low Gestational Age Neonates Does Not Alter Risk of Retinopathy of Prematurity, Jorge Perez, Magaly Diaz-Barbosa, Edshelee Galvis, and Susana Bombino
Full Text Restricted – Available from BHSF IP or login only
Prevalence of Acute Kidney Injury (AKI) in Extremely Low Gestational Age Neonates (ELGAN), Jorge Perez, Magaly Diaz-Barbosa, Arturo Serize, Jorge Jordan, Edshelee Galvis, Susana Bombino, Lauren Carbonell, Anna Maria Patino-Fernandez, Carmen de Lerma, Kelly McDonough, and Maiana De Cortada
Full Text Restricted – Available from BHSF IP or login only
Aerosolized Calfactant for Newborns With Respiratory Distress: A Randomized Trial, Jorge Perez, Arturo Serize, Jorge Jordan, and Magaly Diaz-Barbosa
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2019
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320), Jorge Perez and Arturo Serize
Full Text Restricted – Available from BHSF IP or login only
Lack of Equipoise in the PDA-TOLERATE Trial: A Comparison of Eligible Infants Enrolled in the Trial and Those Treated Outside the Trial, Jorge Perez and Arturo Serize
Full Text Restricted – Available from BHSF IP or login only
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of Age, Jorge Perez and Arturo Serize
Full Text Restricted – Available from BHSF IP or login only
Submissions from 2014
Golden Hour Delivery Room Management Update, Margarita Hernandez